FDA files injunction against sports supplement manufacturer over years-long record of GMP failures

By Hank Schultz

- Last updated on GMT

FDA files injunction against sports supplement manufacturer over years-long record of GMP failures

Related tags Dietary supplements Dietary supplement

Scilabs Nutraceuticals Inc., a California dietary supplement company, has been slapped with a permanent injunction after failing three rounds of FDA inspections and receiving a warning letter in 2013.

The US Court for the Central District of California issued the injunction Wednesday against the Irvine, CA-based company and its CEO, Paul P. Edelat, to prevent the distribution of adulterated dietary supplements, according to the Justice Department.

SciLabs Nutraceuticals Inc. is a contract manufacturer of dietary supplements distributed under the brand name All Pro Science, including Complete Immune + capsules and various flavored powders called Complete, Recovery and Precharge.  The department filed a complaint in the U.S. District Court for the Central District of California at the request of the U.S. Food and Drug Administration (FDA), alleging that the company’s dietary supplements are manufactured under conditions that are inadequate to ensure the quality of its products. 

Cessation of operations

In conjunction with the filing of the complaint, the defendants agreed to settle the litigation and be bound by a consent decree of permanent injunction that prohibits them from committing violations of the Federal Food, Drug, and Cosmetic Act.  The consent decree requires the dietary supplement manufacturer to cease all operations and requires that, in order for defendants to resume manufacturing dietary supplements, the FDA first must determine that Scilabs’ manufacturing practices have come into compliance with the law. 

According the complaint, FDA performed inspections in 2012, 2013 and 2014 all of which found serious GMP violations at the company’s manufacturing plant. For example, the complaint alleges that the company failed to conduct at least one appropriate test or examination to verify the identity of every dietary ingredient before using them.  The company also allegedly failed to establish product specifications for the identity, purity, strength and composition of finished batches of dietary supplements.  In addition the company failed to keep proper equipement logs documenting the use, maintenance, cleaning and sanitization of individual pieces of equipment.

A permanent injunction is the end of a long road noncompliant companies take with FDA.  While it is an arrow in the agency’s quiver, it is one only rarely notched to the bow, though that seems to be changing, according to Marc Ullman, an attorney with the firm Ullman, Shapiro & Ullman.

“You have to push FDA pretty hard to get them to slap an injunction on you. That being said, injunctions seem to be becoming less uncommon over time,”​ Ullman told NutraIngredients-USA.

2013 warning letter

Along with the unsatisfactory inspections, FDA sent a warning letter to SciLabs in January, 2013.  The warning letter listings “serious violations”​ of the GMP regulations that were discovered in two inspections in 2012 including:

1. Failure to establish required quality control specifications for select points, steps, or stages in the manufacturing process.

2. Failure to test the identity of dietary ingredient components, and to confirm the identity of other components.  

3. Failure to prepare and follow a written master manufacturing record for each unique formulation of a dietary supplement 

4. Failure to complete a batch production records 

5. Failure to establish and follow written procedures for calibration of instruments and controls

FDA also alleged the company misbranded dietary supplements by failing to “include a domestic address or domestic phone number through which the responsible person may receive a report of a serious adverse event with such dietary supplements”​.

To read the full warning letter, please click here​.

After receiving that letter, SciLabs was inspected at least two other times.  In the court complaint filed on Nov. 5, FDA said “[SciLabs] have previously violated the act. Several of the [violations] observed during the most recent inspection are the same as, or similar to, those observed by FDA during a previous inspection of [SciLabs’] facility on Sept. 17-20, 25, and Oct. 25, 2013.”

Divided attention

During at least a portion of its interaction with FDA Scilabs’ attention seemed to have been directed elsewhere. The company was embroiled in a breach of contract lawsuit with former NFL player Tony Gonzalez (who cofounded the All Pro Science brand with Edelat) and in late 2012 it hired a high profile public relations firm called MSW Communications Group to handle public relations surrounding the litigation.

It’s an open question whether SciLabs can resume operation.  In theory it’s possible, assuming the company can revamp its operations and then satisfy FDA that it can operate within the law in the future.  But’s it's unlikely, Ullman said, because of the time and money involved and because the effort would require a complete overhaul of the company’s corporate culture.

“It’s rare for companies to be able to resume operations, given what’s involved,”​ Ullman said. “The injunctions invariably require FDA to sign off before you can start up again.”

Related news

Related products

show more

Pycnogenol® for Sport: eNOS and Beyond

Pycnogenol® for Sport: eNOS and Beyond

Content provided by Horphag Research | 21-Mar-2024 | White Paper

Engaging in physical activities immediately triggers a number of physiological responses from our body (1). First, our liver glucose output and adipose...

LocVita® D3: Tailored Formulas & Beadlet Solutions

LocVita® D3: Tailored Formulas & Beadlet Solutions

Content provided by INNOBIO Corporation Limited | 11-Mar-2024 | White Paper

LocVita® Vegan Vitamin D3 delivers specially formulated options that are sugar-free and organic, designed to accommodate various dietary preferences and...

MOROSIL:INGREDIENT OF THE YEAR

MOROSIL:INGREDIENT OF THE YEAR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Mar-2024 | Product Brochure

MOROSIL™ has won as Ingredient of the Year in the category Weight Management at 2023 Nutraingredient USA. MOROSIL ™ is a standardized extract derived from...

Stay one step ahead in the collagen market

Stay one step ahead in the collagen market

Content provided by Bioiberica | 26-Feb-2024 | White Paper

It's no secret that interest in collagen is at an all-time high – especially for joint health. This presents a real opportunity for manufacturers...

Related suppliers

2 comments

Fed Up! Times Up! Time to Fire the FDA & the FTC

Posted by Sandra Hornsby White,

I began in the 1960's standing outside my local Mom and Pop Health Food Store to keep it open and Thompson's Acerola Plus Vitamin C on the shelves. Why? Because it would change the course of cancer and cell health for myself and family members dying from Cancer. I gathered Petition Sigs made copies and walk them over two blocks to the State Capitol and then mailed them to DC...."hands off my nutrients". The Corruption of the FDA, Big Pharma, AMA along with Congressman Henry Waxman, the author of The National Health Care Plan has been caught over and over again writing bills and selling seats on the Commissioners Board and granting "key politicians" and Pharmaceutical Reps the cake walk to write and market their own White Paper for instant approval and the triple digit incomes . Hefty penalties, including prison terms for consultants and consumers of all natural food supplements. This includes in the Wall Street Bail Out! Because of the Action by the FDA....signals to me that his company must be a really good company and making money with a superior product or the FDA would not bother. Because the FDA targets successful companies to begin the FTC and the Attorney General of the State to begin prosecution and racking up the coin with heft fines and class action lawsuits at the State Level. This ultimately grants the existence of these Government Agencies and ensures this trillion dollar loop continues to prosper in the "sick medicine industry"

Report abuse

To Common

Posted by Dr. Neil Ross,

The practices outlined are still to common in the industry.
I have seen them at numerous sites. SLOWLY the industry is matching up to requirements for cGMP, but in many cases it is either money or will that are the issues.

Report abuse

Follow us

Products

View more

Webinars